TRION Pharma Release: Trifunctional Antibody Catumaxomab Triggers Vaccination Effect Against Cancer
6/6/2011 12:33:21 PM
More...
|
TRION Pharma: Trifunctional Antibody Catumaxomab Kills Cancer Stem Cells
6/2/2009 3:29:54 PM
More...
|
TRION Pharma Release: EU Approval for Removab(R): First Trifunctional Antibody Hits Market
4/24/2009 10:28:08 AM
More...
|
Positive CHMP Opinion for Removab(R) Validates TRION Pharma’s Triomab(R) Technology
2/19/2009 1:13:25 PM
More...
|
TRION Pharma Announces Positive Phase I Data Demonstrate Feasibility of Intraoperative Administration of Trifunctional Anti-Cancer Antibody Catumaxomab (removab(R))
1/28/2008 11:24:53 AM
More...
|